Woody Joseph Fralin purchased $85K of RCEL
Woody Joseph Fralin purchased 20,000 shares of AVITA Medical, Inc. (RCEL) at an average of $4.25 ($4.18–$4.34) across 4 trades over 2026-06-01 to 2026-06-02.
How this was made
The 30-second read
Why it matters
A director's purchase may be interpreted as confidence, but the amount ($85K) is modest relative to typical market volume.
Market read
Primary insider purchase with limited material impact; may generate slight positive sentiment.
What to watch
If the director has additional undisclosed holdings or upcoming corporate actions, the trade could be more material.
Background
SEC Form 4 filing discloses insider transactions. Avita Medical (RCEL) is a micro‑cap listed on Nasdaq.
Ticker impact
Director Woody Joseph Fralin bought 20,000 shares for $84,936, increasing his stake to 20,000 shares.
likely slight upward pressure as market prices in insider confidence
The purchase is small relative to market cap but represents a director buying at $4.25 average, which can be viewed as a positive signal.
Market effects
Minimal impact on the medical device sector; only a micro‑cap insider trade.
Limited to U.S. over‑the‑counter investors in RCEL.
Low
Counterpoint
The purchase size is too small to move the stock; traders may ignore it.
Key entities
- companyAvita Medical, Inc.
Issuer of the shares purchased.
- personWoody Joseph Fralin
Director of Avita Medical who made the purchase.
